Home ▸ News Release ▸ E-Cigarettes Can Help Smokers Quit, But There’s a Catch

E-Cigarettes Can Help Smokers Quit, But There’s a Catch

Posted in News Release | Tagged cancer

WASHINGTON (Aug. 31, 2017) — Frequent e-cigarette use does help smokers quit — a finding that Georgetown Lombardi Comprehensive Cancer Center (new window) researchers say supports the use of e-cigarettes as a cessation aid for those trying to quit cigarette smoking. But, they note, an examination of a recent national survey uncovers important clues about who’s successful at quitting and why.

The findings, published in Nicotine & Tobacco Research, examined a national survey of more than 24,500 current or recent former cigarette smokers, which is the largest sample of smokers studied to date. This study, along with a July study published in the BMJ (new window), provide some of the strongest evidence so far on the link between use of e-cigarettes and cessation, says the study’s lead author David Levy, PhD, professor of oncology at Georgetown Lombardi.

However, Levy notes, there are important nuances in the data that impact a person’s success in quitting cigarette smoking.

“Both cigarette quit attempts and quit success were directly related to the number of days of e-cigarette use,” Levy explains. “The odds of quit success increased by 10 percent with each additional day of e-cigarette use.”

The data also show that among those making at least one quit attempt, quit success was lower among individuals who had used e-cigarettes at some point in the past, but higher among those with at least 5 days of e-cigarettes use in the last month.

The data is drawn from a special tobacco use survey that, since 1992-1993, has been taken every 3-4 years as part of a population survey conducted monthly by the U.S. Census Bureau. The latest tobacco use survey, taken from 2014-2015, was co-sponsored by the National Cancer Institute and the U.S. Food and Drug Administration.

This survey, the Tobacco Use Supplement to the Current Population Survey (TUS-CPS) (new window), is designed to track long-term trends in tobacco use, cessation attempts and tobacco-related policies. All states are represented, and participants are interviewed either by telephone or in person.

The latest TUS-CPS consisted of three samples collected in July 2014, and in January and May of 2015. These samples included more than 150,000 respondents.

Levy and his Georgetown Lombardi colleagues examined the relationship between frequency of e-cigarette use, cigarette quit attempts and cigarette abstinence. Because of the dates of the survey, it includes the more current types of e-cigarettes that are more effective at delivering nicotine.

“Our findings are consistent with randomized trials and those observational studies that measure frequency of e-cigarette use. These results support the use of e-cigarettes — especially, consistent use — as an effective smoking cessation aid. Since e-cigarettes are generally estimated to have a small proportion of the mortality risks of cigarettes, this represents an important life-saving intervention that doctors can recommend when other forms of treatment fail,” says Levy.

Study co-authors include Zhe Yuan, MS, Yuying Luo, MS, and David B. Abrams, PhD, all members of Georgetown Lombardi Comprehensive Cancer Center.

The authors report having no personal financial interests related to the study.

The study was funded by grants from the National Institute of Drug Abuse (R01DA036497) and the National Cancer Institute (P01-CA200512).

About Georgetown Lombardi Comprehensive Cancer Center (new window)

Georgetown Lombardi Comprehensive Cancer Center is designated by the National Cancer Institute as a comprehensive cancer center — the only cancer center of its kind in the Washington, DC area. A part of Georgetown University Medical Center and MedStar Georgetown University Hospital, Georgetown Lombardi seeks to improve the diagnosis, treatment, and prevention of cancer through innovative basic and clinical research, patient care, community education and outreach, and the training of cancer specialists of the future. Connect with Georgetown Lombardi on Facebook (new window) (Facebook.com/GeorgetownLombardi (new window)) and Twitter (new window)(@LombardiCancer (new window)).

About Georgetown University Medical Center (new window)

Georgetown University Medical Center (GUMC) is an internationally recognized academic medical center with a three-part mission of research, teaching and patient care (through MedStar Health). GUMC’s mission is carried out with a strong emphasis on public service and a dedication to the Catholic, Jesuit principle of cura personalis — or “care of the whole person.” The Medical Center includes the School of Medicine and the School of Nursing & Health Studies, both nationally ranked; Georgetown Lombardi Comprehensive Cancer Center, designated as a comprehensive cancer center by the National Cancer Institute; and the Biomedical Graduate Research Organization, which accounts for the majority of externally funded research at GUMC including a Clinical and Translational Science Award from the National Institutes of Health. Connect with GUMC on Facebook (new window) (Facebook.com/GUMCUpdate (new window)) and Twitter (new window)(@gumedcenter (new window)).